ASTERASYS Co.,Ltd (KOSDAQ:450950)
South Korea · Delayed Price · Currency is KRW 11,470
-10 (-0.09%)
At close: Apr 29, 2026
ASTERASYS Co.,Ltd Revenue
In the year 2025, ASTERASYS Co.,Ltd had annual revenue of 37.94B KRW with 31.60% growth. ASTERASYS Co.,Ltd had revenue of 12.17B in the quarter ending December 31, 2025, with 13.76% growth.
Revenue
37.94B
Revenue Growth
+31.60%
P/S Ratio
11.28
Revenue / Employee
412.43M
Employees
92
Market Cap
427.83B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 37.94B | 9.11B | 31.60% |
| Dec 31, 2024 | 28.83B | 11.34B | 64.78% |
| Dec 31, 2023 | 17.50B | 1.88B | 12.04% |
| Dec 31, 2022 | 15.62B | 1.56B | 11.06% |
| Dec 31, 2021 | 14.06B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| MEDIANA Co.,Ltd | 64.94B |
| JPI Healthcare | 48.47B |
| L&K Biomed | 38.92B |
| Hironic | 32.09B |
| SELVAS Healthcare | 30.82B |
| Remed | 24.50B |
| Next Biomedical | 16.48B |
| Neofect | 16.05B |